Clinical characteristics and genetic analysis of maturity-onset diabetes of the young type 2 diagnosed in childhood.
10.7499/j.issn.1008-8830.2408032
- Author:
Juan YE
1
;
Feng YE
1
;
Ling HOU
1
;
Wei WU
1
;
Xiao-Ping LUO
1
;
Yan LIANG
1
Author Information
1. Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology/Hubei Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Wuhan 430030, China.
- Publication Type:Journal Article
- Keywords:
Child;
GCK gene;
Genotype;
Maturity-onset diabetes of the young type 2;
Monogenic diabetes
- MeSH:
Humans;
Diabetes Mellitus, Type 2/diagnosis*;
Male;
Female;
Child;
Retrospective Studies;
Glucokinase/genetics*;
Adolescent;
Child, Preschool;
Glucose Tolerance Test
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(1):94-100
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To study the clinical manifestations and genetic characteristics of children with maturity-onset diabetes of the young type 2 (MODY2), aiming to enhance the recognition of MODY2 in clinical practice.
METHODS:A retrospective analysis was conducted on the clinical data of 13 children diagnosed with MODY2 at the Department of Pediatrics of Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology from August 2017 to July 2023.
RESULTS:All 13 MODY2 children had a positive family history of diabetes and were found to have mild fasting hyperglycemia [(6.4±0.5) mmol/L] during health examinations or due to infectious diseases. In the oral glucose tolerance test, two cases met the diagnostic criteria for diabetes with fasting blood glucose, while the others exhibited impaired fasting glucose or impaired glucose tolerance. The one-hour post-glucose load (1-hPG) fluctuated between 8.31 and 13.06 mmol/L, meeting the diagnostic criteria for diabetes recommended by the International Diabetes Federation. All 13 MODY2 children had heterozygous variants in the glucokinase (GCK) gene, with Cases 6 (GCK c.1047C>A, p.Y349X), 11 (GCK c.1146_1147ins GCAGAGCGTGTCTACGCGCGCTGCGCACATGTGC, p.S383Alafs*87), and 13 (GCK c.784_785insC, p.D262Alafs*13) presenting variants that had not been previously reported.
CONCLUSIONS:This study enriches the spectrum of genetic variations associated with MODY2. Clinically, children with a family history of diabetes, incidental findings of mild fasting hyperglycemia, and negative diabetes-related antibodies should be considered for the possibility of MODY2.
